|
Name |
Coleon U 12-methyl ether
|
| Molecular Formula | C21H28O5 | |
| IUPAC Name* |
5,8,10-trihydroxy-6-methoxy-1,1,4a-trimethyl-7-propan-2-yl-3,4-dihydro-2H-phenanthren-9-one
|
|
| SMILES |
CC(C)C1=C(C2=C(C(=C1OC)O)C3(CCCC(C3=C(C2=O)O)(C)C)C)O
|
|
| InChI |
InChI=1S/C21H28O5/c1-10(2)11-14(22)12-13(16(24)18(11)26-6)21(5)9-7-8-20(3,4)19(21)17(25)15(12)23/h10,22,24-25H,7-9H2,1-6H3
|
|
| InChIKey |
QWFMIWDUMBELIV-UHFFFAOYSA-N
|
|
| Synonyms |
Coleon U 12-methyl ether; NSC647732; 5,8,10-trihydroxy-7-isopropyl-6-methoxy-1,1,4a-trimethyl-3,4-dihydro-2H-phenanthren-9-one; (R)-2,3,4,4a-tetrahydro-5,8, 10-trihydroxy-6-methoxy-1,1, 4a-trimethyl-7-(1-methylethyl)-9(1H)-phenanthrenone
|
|
| CAS | NA | |
| PubChem CID | 495262 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 360.4 | ALogp: | 5.4 |
| HBD: | 3 | HBA: | 5 |
| Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 87.0 | Aromatic Rings: | 3 |
| Heavy Atoms: | 26 | QED Weighted: | 0.636 |
| Caco-2 Permeability: | -4.789 | MDCK Permeability: | 0.00001830 |
| Pgp-inhibitor: | 0.58 | Pgp-substrate: | 0.001 |
| Human Intestinal Absorption (HIA): | 0.026 | 20% Bioavailability (F20%): | 0.012 |
| 30% Bioavailability (F30%): | 0.018 |
| Blood-Brain-Barrier Penetration (BBB): | 0.059 | Plasma Protein Binding (PPB): | 99.81% |
| Volume Distribution (VD): | 0.551 | Fu: | 1.50% |
| CYP1A2-inhibitor: | 0.466 | CYP1A2-substrate: | 0.943 |
| CYP2C19-inhibitor: | 0.573 | CYP2C19-substrate: | 0.816 |
| CYP2C9-inhibitor: | 0.756 | CYP2C9-substrate: | 0.902 |
| CYP2D6-inhibitor: | 0.467 | CYP2D6-substrate: | 0.279 |
| CYP3A4-inhibitor: | 0.344 | CYP3A4-substrate: | 0.346 |
| Clearance (CL): | 1.115 | Half-life (T1/2): | 0.076 |
| hERG Blockers: | 0.005 | Human Hepatotoxicity (H-HT): | 0.045 |
| Drug-inuced Liver Injury (DILI): | 0.487 | AMES Toxicity: | 0.099 |
| Rat Oral Acute Toxicity: | 0.309 | Maximum Recommended Daily Dose: | 0.497 |
| Skin Sensitization: | 0.746 | Carcinogencity: | 0.045 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.874 |
| Respiratory Toxicity: | 0.958 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC001048 | ![]() |
0.797 | D0WY9N | ![]() |
0.289 | ||
| ENC002308 | ![]() |
0.323 | D01CKY | ![]() |
0.234 | ||
| ENC005919 | ![]() |
0.312 | D01XWG | ![]() |
0.213 | ||
| ENC001084 | ![]() |
0.304 | D0R6RC | ![]() |
0.213 | ||
| ENC004922 | ![]() |
0.296 | D06GCK | ![]() |
0.212 | ||
| ENC000709 | ![]() |
0.296 | D0T5XN | ![]() |
0.211 | ||
| ENC005342 | ![]() |
0.295 | D08NQZ | ![]() |
0.206 | ||
| ENC002036 | ![]() |
0.290 | D07MGA | ![]() |
0.206 | ||
| ENC005550 | ![]() |
0.290 | D05AFR | ![]() |
0.204 | ||
| ENC002307 | ![]() |
0.290 | D02GAC | ![]() |
0.203 | ||